GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
190 hedge funds and large institutions have $2.32B invested in Global Blood Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 184 → 190 (+6)
5% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 62
Holders
190
Holding in Top 10
10
Calls
$78.3M
Puts
$23.2M
Top Buyers
| 1 | +$48.4M | |
| 2 | +$44.9M | |
| 3 | +$28.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.4M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.8M |
Top Sellers
| 1 | -$30.6M | |
| 2 | -$20.8M | |
| 3 | -$16.6M | |
| 4 |
NC
Nexthera Capital
New York
|
-$13.4M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$12.3M |